Assessment of Plasmodium falciparum anti-malarial drug resistance markers in pfk13-propeller, pfcrt and pfmdr1 genes in isolates from treatment failure patients in Democratic Republic of Congo, 2018–2019

BACKGROUND: The national policy for malaria treatment of the Democratic Republic of Congo recommends two first-line artemisinin-based combinations for the treatment of uncomplicated malaria: artesunate-amodiaquine and artemether-lumefantrine. This study investigated the presence of markers associate...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Malar J
Autors principals: Yobi, Doudou M., Kayiba, Nadine K., Mvumbi, Dieudonné M., Boreux, Raphael, Kabututu, Pius Z., Situakibanza, Hippolyte N. T., Umesumbu, Solange E., De Mol, Patrick, Speybroeck, Niko, Mvumbi, Georges L., Hayette, Marie-Pierre
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2021
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7953712/
https://ncbi.nlm.nih.gov/pubmed/33706773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-021-03636-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars